Hi Skint,Isn’t this new more reason to say NO to the offer by...

First 6 Last

Share
Profile

Follow
pierre77

1,382 Posts.

54

06/03/19

13:06

Post #: 37670995
Share

Originally posted by skint: ↑

Most interesting to me was at the very end of the independent report. Very sorry for long term investors.
[Given that Life Biosciences will have up to a 59.6% interest in Prana after theProposed Subscription if it exercises all its Warrants, it is possible that LifeBiosciences might take over the whole Company in the future. If this happens witha favourable offer, for example an offer price that is at a premium to the shareprice or fair value per share then, the Shareholders could benefit from thetakeover.]

[Following the completion of the Proposed Subscription, the Non-AssociatedShareholders will have their current shareholdings significantly diluted from 100%to 67.0%, and further to 40.4% if Life Biosciences exercises all the Warrants.Therefore, the Non-Associated Shareholders may receive significantly lessdistribution of profits or proceeds from any future sale of Prana.]

[Given that Life Biosciences will have up to a 59.6% interest in Prana after theProposed Subscription if it exercises all its Warrants, it is possible that LifeBiosciences might take over the whole Company in the future. If this happens withan unfavorable offer, for example an offer price that is at a discount to the shareprice or fair value per share then, the Shareholders could suffer (on monetaryterms) from the takeover]

[Life Biosciences will become a majority shareholder and have up to a 59.6%interest in Prana after the Proposed Subscription if it exercises all of its Warrants.This significant shareholding held by Life Biosciences could reduce the tradingliquidity of Prana’s shares (and potentially exert downward pressure on the shareprice) and reduce the attractiveness of Prana as a takeover target by the otherinvestors which could be favorable to the Shareholders.]

Expand

Hi Skint,

Isn’t this new more reason to say NO to the offer by current shareholders? Why would anyone who is currently holding agree to this?

also,
3.3 Name changeSubject to completion of the Subscription, the Company is proposing to change its name to “AlterityTherapeutics Limited”.

PBT Price at posting: 3.8¢ Sentiment: Hold Disclosure: Held
5 Upvote

1 Great analysis

Reply

Top Stories

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

PCL

HotCopper users react as Pancontinental Energy's trading halt lift reveals little

ASX Market Open: Aussie market to leap on best 'Trump trade' bump since election day | November 22, 2024

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

ALY

Alcidion inks deal with Vic health provider Peninsula for use of Miya Precision tech

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

CAF

IP anomaly thrills Cannidah with project extension hopes in QLD

C1X

iTech inks deal with Chilean lithium giant to progress Reynolds Range

CMB

Asian Battery Metals uncover second massive sulphide discovery at Mongolia's Oval play

There are more pages in this discussion • 67 more messages in this thread...

First 6 Last

Add PBT (ASX) to my watchlist

Hi Skint,Isn’t this new more reason to say NO to the offer by...

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

HotCopper users react as Pancontinental Energy's trading halt lift reveals little

ASX Market Open: Aussie market to leap on best 'Trump trade' bump since election day | November 22, 2024

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Alcidion inks deal with Vic health provider Peninsula for use of Miya Precision tech

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

IP anomaly thrills Cannidah with project extension hopes in QLD

iTech inks deal with Chilean lithium giant to progress Reynolds Range

Asian Battery Metals uncover second massive sulphide discovery at Mongolia's Oval play

Featured News